Delivery Order SPE2DB24D3013-SPE2DB25FFNQE
Award Date 7/23/25
Potential Completion Date 7/24/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,964.46 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on July 22, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Zepbound is a glucagon-like peptide-1 receptor agonist used for weight management and diabetes treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $9,973.95 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a glucagon-like peptide-1 receptor agonist used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 ml pens with a ceiling value of $2,726.72. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,305.28 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract involves the delivery of Zepbound, a GLP-1 receptor agonist used for...
- The Defense Logistics Agency awarded a delivery order valued at $30,536.46 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound, a GLP-1 receptor agonist used in diabetes and weight management treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $1,466.05 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management and diabetes treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a ceiling value of $10,647.46. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location and is scheduled for...
- The Defense Logistics Agency awarded a delivery order valued at $11,438.70 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used in diabetes and weight management treatment, reflecting DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $2,139.07 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 14, 2025, with completion expected by August 15, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Zepbound is a pharmaceutical product used in diabetes and weight management treatment, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $3,386.63 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This is a firm fixed-price, non-set-aside delivery order with a completion date of August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used in diabetes and weight management treatment, representing a specialized pharmaceutical...